Skip to content

Homeopathy for difficulties in holding urine in older adults

Efficacy of individualized homoeopathic medicines in the treatment of urinary incontinence in geriatric people: A double-blind, randomized, placebo-controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094501
Enrollment
106
Registered
2025-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R32- Unspecified urinary incontinence

Interventions

Intervention1: Individualized Homoeopathic Medicines: This group will be provided with homoeopathic remedies along with concomitant care. Individualized homoeopathic medicines will be administered in

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from urinary incontinence. ICD-11 code MF50.2 Urinary incontinence. Leakage of urine with or without control. 2.Age 60 ? 75 years. 3.Participants of either sex or transgender. 4.Literate patients ability to read English, Hindi and or Bengali. Illiterate patient will be interviewed by the investigators maintaining adequate privacy to fill up the scales questionnaires.

Exclusion criteria

Exclusion criteria: 1.Not willing to provide with written informed consent of voluntary participation. 2.Patients having neurological conditions, such as known multiple sclerosis, clinically significant peripheral neuropathy or spinal cord injury. 3.Patient who has been dealing with urinary symptoms with several modern medication in the past one month or any plan to have surgical treatment during the study. 4.Participants will be excluded if they had uterine prolapsed grade 3 or 4, vesicovaginal fistula; and any severe cardio-vascular diseases, uncontrolled diabetics. 5.Patient will be excluded if they had urinary tract infections, in urine microscopy - the presence above of 10 leukocytes per mm3 of uncentrifuged urine or 10 leukocytes per hpf of the centrifuged sample, in a clinically suspected UTI. Patients with haematuria recurrent and persistent, proteinuria. 6.Patients with BHP who require intervention beyond conservative management.e.g., surgical or invasive procedures. Patient with serum prostate specific antigen, PSA more than 10 nmol per ml. 7.Vulnerable population ? unconscious, too sick for consultation or ambulatory, differently abled, terminally ill patients, mentally incompetent people etc. 8.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 9.Self-reported immune-compromised state, and already undergoing homoeopathic treatment for chronic disease within last 4 weeks. 10.Patient under tobacco chewing and or smoking, alcoholism and or any other forms of substance abuse and or dependence.

Design outcomes

Primary

MeasureTime frame
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI-SF)Timepoint: Baseline, and every month , upto 6 months

Secondary

MeasureTime frame
Quality of Life Assessment Questionnaire Concerning Urinary Incontinence (Contilife)Timepoint: Baseline, and every month, up to 6 months

Countries

India

Contacts

Public ContactDr Saima Shamim

D N De Homoeopathic Medical College & Hospital

jagadishghosh688@gmail.com7478203150

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026